RE:RVV will do fine. It's in a niche as a reactive drug(s)
RandomGuy1 wrote: There's been thousands of deaths attributed to the vaccine in the USA alone so not everyone is willing to take it.
If the trial is a success it won't matter what is in place as a therapeutic, RVV will see huge gains. Even vaccinated there is no guarantee you won't get sick, mild illness is a possibility. Also if efficacy suffers over time there will be a period where additional people will suffer mild symptons.